TELEKAST 5 MG CHEW

Telekast 5 Chewable Tablet is indicated for the prevention of asthma episodes in children and can also assist in alleviating breathing issues that arise from intense physical exertion. Additionally, the tablet is effective in managing symptoms associated with seasonal allergies, including nasal congestion, sneezing, and eye irritation characterized by itchiness or excessive tearing. It is essential to administer Telekast 5 Chewable Tablet to your child consistently, either before or after meals, as directed by the healthcare provider. The medication may require a few weeks of consistent use before its full effects on asthma prevention are observed. For asthma management, it is recommended to administer the tablet in the evening or two hours in advance of any physical activity. In cases of allergies, timing should be based on when symptoms first emerge, although evening administration is typically preferred. If a dose is vomited within 30 minutes of administration, it is advisable to repeat the dose unless it is nearing the time for the subsequent scheduled dose. Parents should be aware that while initial doses may lead to improvements, it is crucial to adhere to the prescribed regimen to achieve the best results. Abrupt cessation of this medication can lead to a deterioration of asthma control. Minor and temporary adverse effects, such as fever, headaches, stomach discomfort, or diarrhea, may occur but generally resolve as the child’s body adjusts to the treatment. Should these side effects persist or cause significant concern, a consultation with the child’s healthcare provider is recommended. Inform the healthcare provider of any other medications your child is taking and provide a complete medical history, including any previous allergies, cardiovascular issues, blood disorders, vascular conditions, congenital anomalies, respiratory blockages, lung issues, dermatological problems, or any form of liver or kidney dysfunction. This information is vital for proper dosage adjustments and overall treatment planning.